The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

ResMed Inc

NYSE: RMD
Last

(U.S.) $65.33

Today's change+1.07 +1.67%
Updated January 13 4:02 PM EST. Delayed by at least 15 minutes.
 

ResMed Inc

NYSE: RMD
Last

(U.S.) $65.33

Today's change+1.07 +1.67%
Updated January 13 4:02 PM EST. Delayed by at least 15 minutes.

ResMed Inc Hits New 50-day High

ResMed Inc closed up sharply Friday, rallying (U.S.)$1.07 or 1.67% to (U.S.)$65.33 and setting a new 50-day high. Over the last five days, shares have gained 5.13% and outperformed the S&P 500 index over the last 52 weeks with a 22.99% increase in price.

Key company metrics

  • Open(U.S.) $64.68
  • Previous close(U.S.) $64.26
  • High(U.S.) $65.78
  • Low(U.S.) $64.52
  • Bid / Ask-- / --
  • YTD % change+5.29%
  • Volume696,496
  • Average volume (10-day)611,655
  • Average volume (1-month)744,796
  • Average volume (3-month)883,813
  • 52-week range(U.S.) $52.37 to (U.S.) $70.90
  • Beta0.82
  • Trailing P/E26.56×
  • P/E 1 year forward23.72×
  • Forward PEG2.31×
  • Indicated annual dividend(U.S.) $1.32
  • Dividend yield2.02%
  • Trailing EPS(U.S.) $2.46
Updated January 13 4:02 PM EST. Delayed by at least 15 minutes.
S&P TSX0.12%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue465519454455
Total other revenue--------
Total revenue465519454455
Gross profit269301260267
Total cost of revenue196217194188
Total operating expense371400350347
Selling / general / administrative129136123118
Research & development34342829
Depreciation / amortization121354
Interest expense (income), net operating--------
Unusual expense (income)--007
Other operating expenses, total--------
Operating income94119104108
Interest income (expense), net non-operating---11----
Gain (loss) on sale of assets--------
Other--------
Income before tax93117109114
Income after tax76938891
Income tax, total17242123
Net income76938891
Total adjustments to net income--------
Net income before extra. items76938891
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items76938891
Inc. avail. to common incl. extra. items76938891
Diluted net income76938891
Dilution adjustment00----
Diluted weighted average shares142142141141
Diluted EPS excluding extraordinary itemsvalue per share0.540.660.630.64
Dividends per sharevalue per share0.330.300.300.30
Diluted normalized EPSvalue per share0.540.660.630.68